Table 1.

Fixed effects parameter estimates of change in SE, OE, worry, and depressive symptoms over time

Fixed effects	GSE	PATHEVH	PSWQ	BDI‐II
Intercept
γ (SE)	29.87 (3.22)	12.34 (2.05)	25.45 (4.62)	15.72 (4.32)
t	9.29***	6.02***	5.51***	3.64***
Linear time
γ (SE)	0.23 (0.04)	0.07 (0.02)	−1.06 (0.10)	−0.75 (0.08)
t	6.10***	3.09**	−10.99***	−9.66***
Phase
γ (SE)	2.31 (0.45)	‐	−13.83 (1.13)	−8.51 (0.91)
t	5.08***		12.20***	−9.32***
Time x Phase
γ (SE)	−0.19 (0.04)	‐	1.02 (0.10)	0.73 (0.08)
t	−5.02***		10.32***	9.21***
Baseline PSWQ
γ (SE)	−0.04 (0.05)	0.07 (0.03)	0.54 (0.07)	−0.12 (0.07)
t	−0.77	1.98	7.17***	−1.67
Baseline BDI‐II
γ (SE)	−0.11 (0.05)	−0.08 (0.03)	0.02 (0.07)	0.45 (0.07)
t	−2.12*	−2.35*	0.28	6.69***
Comorbidity
γ (SE)	−1.99 (0.82)	−0.08 (0.53)	2.90 (1.19)	2.74 (1.10)
t	−2.42*	−0.16	2.27*	2.48*
Condition
γ (SE)	1.10 (0.75)	0.18 (0.51)	1.61 (1.16)	−1.07 (1.00)
t	1.47	0.36	1.39	−1.08

Abbreviations: BDI‐II, Beck Depression Inventory—Second Edition; GSE, General Self‐Efficacy Scale; OE, outcome expectation; PATHEVH, Therapy Expectation and Evaluation scale, Hope of Improvement subscale; PSWQ, Penn State Worry Questionnaire; SE, self‐efficacy.

^* p < 0.05;

^** p < 0.01;

^*** p < 0.001.